Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level908 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (459)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01247506 | Different Genetic Features Associated With Hepatic Carcinogenesis | unknown | — | 160 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2010 | clinicaltrials |
| NCT01230697 | Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)(SORHORM) | unknown | — | 60 | University of Turin, ItalyOTHER |
| 1 |
| Oct 29, 2010 |
| clinicaltrials |
| NCT00179816 | Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | unknown | Phase 1 / Phase 2 | 12 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT01201655 | Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis | unknown | — | 5,000 | Xijing HospitalOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT01182272 | Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 36 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01178801 | Sharable Knowledge Mining Platform | unknown | — | 10,000 | National Taiwan University HospitalOTHER | 1 | Aug 10, 2010 | clinicaltrials |
| NCT00501813 | Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion(MDTforHCC) | unknown | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2010 | clinicaltrials |
| NCT00561522 | Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection | unknown | Phase 2 / Phase 3 | 290 | Fudan UniversityOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00563095 | A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer | unknown | N/A | 100 | Hospital Authority, Hong KongOTHER_GOV | 1 | Jul 7, 2010 | clinicaltrials |
| NCT01125020 | Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation | unknown | N/A | 150 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 18, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT01102335 | Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy(TACEHBV) | unknown | Phase 4 | 80 | Fudan UniversityOTHER | 1 | Apr 13, 2010 | clinicaltrials |
| NCT01078311 | Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma(DOSE-HEP) | unknown | — | 100 | South West Sydney Local Health DistrictOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00707681 | Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) | unknown | Phase 2 | 60 | Microbio Co LtdINDUSTRY | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00834860 | Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma | unknown | Phase 4 | 179 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Feb 15, 2010 | clinicaltrials |
| NCT00848952 | Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis(CHIC) | unknown | N/A | 450 | University Hospital, AngersOTHER_GOV | 1 | Feb 4, 2010 | clinicaltrials |
| NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | unknown | Phase 2 | 250 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT01039181 | Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 28 | National Science and Technology Development Agency, ThailandOTHER_GOV | 1 | Dec 24, 2009 | clinicaltrials |
| NCT01033578 | Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis | unknown | N/A | 260 | Fudan UniversityOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00960167 | A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) | unknown | Phase 1 | 20 | National Taiwan University HospitalOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00960518 | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)(TACE) | unknown | Phase 2 | 216 | Tongji UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00390195 | Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 134 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00902902 | A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark | unknown | — | 0 | Peking Union Medical College HospitalOTHER | 1 | May 15, 2009 | clinicaltrials |
| NCT00842647 | Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma(HCC) | unknown | — | 1,200 | Sun Yat-sen UniversityOTHER | 1 | Apr 8, 2009 | clinicaltrials |
| NCT00555334 | Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(LAM-RFA) | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 1, 2009 | clinicaltrials |
| NCT00844688 | Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)(HCC) | unknown | Phase 2 | 30 | Combined Military Hospital, PakistanOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00554905 | Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma(RFA and TACE) | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2009 | clinicaltrials |
| NCT00384800 | A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 41 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00720668 | The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma(HBV-HCC) | unknown | — | 200 | Sun Yat-sen UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00728078 | Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(LDT-RFA) | unknown | Phase 2 / Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00768157 | Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00518557 | Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis(TACE HCC) | unknown | N/A | 60 | Southeast University, ChinaOTHER | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00805896 | Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00797251 | Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression | unknown | — | 10 | University of MilanOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00556803 | TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma(TACE-RFA) | unknown | Phase 4 | 120 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00557024 | Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(RT-RFA) | unknown | Phase 4 | 80 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00752063 | Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma(SECOX) | unknown | Phase 2 | 52 | The University of Hong KongOTHER | 1 | Sep 15, 2008 | clinicaltrials |
| NCT00687778 | 11C-Acetate PET/CT Non-FDG-Avid Tumors | unknown | — | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00644020 | Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients | unknown | — | 100 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00629668 | Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease | unknown | N/A | — | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Mar 6, 2008 | clinicaltrials |
| NCT00554125 | Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00460681 | Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00514930 | Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver | unknown | Phase 1 / Phase 2 | — | University of ThessalyOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00474734 | Intravascular Ultrasound for Hepatocellular Carcinoma Staging | unknown | — | — | University Hospital, GenevaOTHER | 1 | May 17, 2007 | clinicaltrials |
| NCT00155103 | Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma | unknown | — | 1,600 | National Taiwan University HospitalOTHER | 1 | Mar 21, 2007 | clinicaltrials |
| NCT00247260 | Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma | unknown | Phase 2 | 50 | pSiVida LimitedINDUSTRY | 1 | Mar 15, 2007 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00356161 | HAI Via Interventionally Implanted Port Catheter Systems | unknown | Phase 2 | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00290316 | Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver | unknown | Phase 2 | — | Central Texas Veterans Health Care SystemOTHER | 1 | Jun 7, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Nov 24, 2010source: clinicaltrials